Business Description
Cryosite Ltd
ISIN : AU000000CTE1
Total Employee Number:
25Description
Cryosite Ltd provides specialised, temperature-controlled logistics and depot services, including secure storage, labelling, secondary packaging, import/export coordination, inventory management, distribution, destruction and reverse logistics. The Group supports Good Manufacturing Practice clinical trial products, Australian Register of Therapeutic Goods approved medicines, biologics, Advanced Therapy Medicinal Products, Research and Development materials and medical devices. Its segments are Ambient, Cold and Frozen, Ultra-frozen and Cryogenic, and Cord Blood. The Ambient, Cold and Frozen segment generates maximum revenue and provides storage and distribution of small-molecule drugs and related products requiring ambient, refrigerated or frozen conditions.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.29 | |||||
Equity-to-Asset | 0.19 | |||||
Debt-to-Equity | 1.59 | |||||
Debt-to-EBITDA | 1.8 | |||||
Interest Coverage | 14.63 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.93 | |||||
Beneish M-Score | -2.51 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.8 | |||||
3-Year EBITDA Growth Rate | 20.9 | |||||
3-Year EPS without NRI Growth Rate | 14 | |||||
3-Year Book Growth Rate | 20.2 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 94.74 | |||||
9-Day RSI | 79.04 | |||||
14-Day RSI | 69.87 | |||||
3-1 Month Momentum % | 13.21 | |||||
12-1 Month Momentum % | 39.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.32 | |||||
Quick Ratio | 1.31 | |||||
Cash Ratio | 0.48 | |||||
Days Inventory | 3.33 | |||||
Days Sales Outstanding | 54.34 | |||||
Days Payable | 70.5 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 62.43 | |||||
Operating Margin % | 18.92 | |||||
Net Margin % | 13.38 | |||||
EBITDA Margin % | 25.64 | |||||
FCF Margin % | -48.19 | |||||
OCF Margin % | 16.89 | |||||
ROE % | 61.81 | |||||
ROA % | 9.32 | |||||
ROIC % | 10.22 | |||||
3-Year ROIIC % | 12.99 | |||||
ROC (Joel Greenblatt) % | 33.29 | |||||
ROCE % | 19.61 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 29.07 | |||||
PE Ratio without NRI | 29.07 | |||||
Shiller PE Ratio | 63.15 | |||||
Price-to-Owner-Earnings | 56.82 | |||||
PEG Ratio | 1.65 | |||||
PS Ratio | 3.86 | |||||
PB Ratio | 12.63 | |||||
Price-to-Tangible-Book | 12.5 | |||||
Price-to-Operating-Cash-Flow | 22.73 | |||||
EV-to-EBIT | 19.73 | |||||
EV-to-EBITDA | 15.53 | |||||
EV-to-Revenue | 3.98 | |||||
EV-to-FCF | -8.26 | |||||
Price-to-GF-Value | 1.23 | |||||
Price-to-Projected-FCF | 31.25 | |||||
Price-to-Median-PS-Value | 1.95 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.64 | |||||
Price-to-Graham-Number | 4.03 | |||||
Earnings Yield (Greenblatt) % | 5.07 | |||||
FCF Yield % | -13.19 | |||||
Forward Rate of Return (Yacktman) % | 17.33 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cryosite Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 16.7 | ||
| EPS (TTM) (A$) | 0.043 | ||
| Beta | -0.7741 | ||
| 3-Year Sharpe Ratio | 0.6 | ||
| 3-Year Sortino Ratio | 1.02 | ||
| Volatility % | 49.16 | ||
| 14-Day RSI | 69.87 | ||
| 14-Day ATR (A$) | 0.008333 | ||
| 20-Day SMA (A$) | 1.2475 | ||
| 12-1 Month Momentum % | 39.53 | ||
| 52-Week Range (A$) | 0.8 - 1.4 | ||
| Shares Outstanding (Mil) | 48.81 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cryosite Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cryosite Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| 1.06056:1 Stock Split | 2004-04-29 | 0.20 (-2.33%) |
Show
Entries
Cryosite Ltd Frequently Asked Questions
What is Cryosite Ltd(ASX:CTE)'s stock price today?
The current price of ASX:CTE is A$1.25. The 52 week high of ASX:CTE is A$1.40 and 52 week low is A$0.80.
When is next earnings date of Cryosite Ltd(ASX:CTE)?
The next earnings date of Cryosite Ltd(ASX:CTE) is .
Does Cryosite Ltd(ASX:CTE) pay dividends? If so, how much?
Cryosite Ltd(ASX:CTE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Cryosite Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers